Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | -2.88% | -4.26% | -31.47% |
May. 13 | Transcript : Iterum Therapeutics plc, Q1 2024 Earnings Call, May 13, 2024 | |
May. 13 | Iterum Therapeutics plc Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 12.13M | Capitalization | 22.35M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -18M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.84 x |
P/E ratio 2024 * |
-0.81
x | P/E ratio 2025 * |
-1.33
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.55% |
Latest transcript on Iterum Therapeutics plc
1 day | -2.88% | ||
1 week | -4.26% | ||
Current month | -11.76% | ||
1 month | -14.01% | ||
3 months | +6.30% | ||
6 months | -41.30% | ||
Current year | -31.47% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Dunne
FOU | Founder | 64 | 15-10-31 |
Corey Fishman
FOU | Founder | 59 | 15-06-23 |
Judith Matthews
DFI | Director of Finance/CFO | 54 | 15-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ron Hunt
CHM | Chairman | 59 | 15-10-31 |
Beth Hecht
BRD | Director/Board Member | 60 | 21-03-11 |
Corey Fishman
FOU | Founder | 59 | 15-06-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 1.35 | -2.88% | 75,403 |
24-05-23 | 1.39 | -2.11% | 101,555 |
24-05-22 | 1.42 | +0.71% | 57,893 |
24-05-21 | 1.41 | -2.76% | 46,158 |
24-05-20 | 1.45 | +2.84% | 124,427 |
Delayed Quote Nasdaq, May 24, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.47% | 22.35M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- ITRM Stock